A heterogeneous pool of tumor precursor cells with self-replenishing and tumor-originating properties in Chronic Lymphocytic Leukemia
B. Budeus, M. Dampmann, A. Kibler, B. Fassbender, M. Brauser, K. Bronischewski, E. Homp, S. Taudien, P. Johansson, J. Bloehdorn, S. Stilgenbauer, J. von Tresckow, J. Duerig, H. C. Reinhardt, R. Kueppers, S. Dietrich, M. Seifert
Abstract
Intratumor heterogeneity (ITH) refers to the coexistence of distinct cancer cell subpopulations within a single tumor, each with unique molecular and functional properties. Understanding the dynamics and evolution of ITH is crucial for predicting tumor progression and the development of therapy resistance. Here, we conducted a comprehensive investigation of ITH in Chronic Lymphocytic Leukemia (CLL) and identified a subpopulation that carried the CLL B-cell receptor rearrangement but contrasted from the CLL main population by low CD5 and high CD20 expression and highly mutated Ig-genes. This CLL-related memory B-cell population shared somatic driver mutations with the main CLL population but also exhibited exclusive somatic mutations. Phylogenetic analysis suggested a pathogenically early generation of these CLL-related B cells before monoclonal B lymphocytosis or CLL manifestation. Our data indicated that CLL-related B cells have self-replenishing potential, as they diminish upon treatment but recover indistinguishably on relapse. This contrasts with the main CLL population, which mostly represents a selective and novel expansion of the CLL-related B cells. This differentiation capacity into conventional CLL cells, and the expression of leukemic stem cell signatures further supported their tumorigenic capacity. We propose that these CLL-related B cells represent a pool of highly diversified, early-stage CLL precursor cells, which persist in the shape of "malignant memory B cells". Longitudinal analyses of these CLL precursor cells suggested that they form a reservoir of malignant, leukemia-originating cells which contribute during disease progression to CLL outgrowth and clonal evolution.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Proliferating CLL cells express high levels of CXCR4 and CD5
Daniel Friedman, Drshika P. Mehtani, … Robbert Hoogeboom·bioRxiv·Dec 27, 2023
- Evolution of chronic lymphocytic leukemia after allogeneic stem cell transplant
Haven R. Garber, Danwei Wang, … Jeffrey J. Molldrem·bioRxiv·Jan 22, 2025
- Decade-long remissions of leukemia sustained by the persistence of activated CD4+ CAR T-cells
J. J. Melenhorst, G. M. Chen, … C. H. June·bioRxiv·May 7, 2021
- Statistics of Cellular Evolution in Leukemia: Allelic Variations in Patient Trajectories Based on Immune Repertoire Sequencing
Hong Gao, Chunlin Wang, … Wenzhong Xiao·bioRxiv·Jan 25, 2016
- Continuous DNA Methylation Deconvolution-Based Surrogate for B-Cell Differentiation State in CLL
Jeffrey R. Hage, Lauren M. Wainman, … Brock C. Christensen·bioRxiv·Sep 16, 2025
- Two-Stage CD8+ CAR T-Cell Differentiation in Patients with Large B-Cell Lymphoma
Guoshuai Cao, Yifei Hu, … Jun Huang·Nature CommunicationsPeer-reviewed·May 6, 2025